Polar Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	$61.2M	Buy	225,037 +53,700	+31%	+$14.6M	0.45%	63
2020 Q2	$49.7M	Buy	171,337 +76,337	+80%	+$22.2M	0.43%	72
2020 Q1	$22.6M	Sell	95,000 -5,000	-5%	-$1.19M	0.24%	118
2019 Q4	$21.9M	Sell	100,000 -25,000	-20%	-$5.47M	0.19%	145
2019 Q3	$21.2M	Sell	125,000 -50,000	-29%	-$8.47M	0.19%	140
2019 Q2	$32.1M	Buy	175,000 +10,000	+6%	+$1.83M	0.28%	114
2019 Q1	$30.4M	Buy	165,000 +40,000	+32%	+$7.36M	0.28%	123
2018 Q4	$20.7M	Sell	125,000 -95,000	-43%	-$15.7M	0.22%	132
2018 Q3	$42.4M	Buy	220,000 +45,000	+26%	+$8.67M	0.36%	88
2018 Q2	$29.7K	Sell	175,000 -317,500	-64%	-$54K	0.18%	119
2018 Q1	$80.3M	Buy	492,500 +275,000	+126%	+$44.8M	0.81%	23
2017 Q4	$32.6M	Buy	217,500 +101,000	+87%	+$15.1M	0.34%	93
2017 Q3	$17.7M	Buy	116,500 +66,500	+133%	+$10.1M	0.2%	129
2017 Q2	$6.44M	Buy	50,000 +35,000	+233%	+$4.51M	0.09%	173
2017 Q1	$1.64M	Hold	15,000	–	–	0.02%	238
2016 Q4	$1.11M	Sell	15,000 -3,500	-19%	-$258K	0.02%	241
2016 Q3	$1.61M	Sell	18,500 -11,181	-38%	-$975K	0.03%	224
2016 Q2	$2.55M	Buy	29,681 +16,768	+130%	+$1.44M	0.05%	210
2016 Q1	$1.03M	Sell	12,913 -5,290	-29%	-$420K	0.02%	234
2015 Q4	$2.29M	Sell	18,203 -324	-2%	-$40.8K	0.04%	208
2015 Q3	$1.93M	Buy	18,527 +8,671	+88%	+$903K	0.04%	219
2015 Q2	$1.22M	Sell	9,856 -6,733	-41%	-$831K	0.02%	247
2015 Q1	$1.96M	Buy	16,589 +12,260	+283%	+$1.45M	0.04%	220
2014 Q4	$514K	Buy	+4,329	New	+$514K	0.01%	258